Evidence map›Paper›PMID 37709252›Full record

ArticleChest2024

Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?

Charles Fauvel, R James White, Rebecca R Vanderpool, Roberto Badagliacca, Tobore Tobore, Mohammad Rahman, Carmine Dario Vizza, Shili Lin, Allen D Everett, Scott H Visovatti and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Chest, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Charles FauvelDepartment of Cardiology, Normandie University, UNIROUEN, U1096, CHU Rouen, Rouen, France.
R James WhiteDepartment of Pulmonary and Critical Care Medicine, University of Rochester, Rochester, NY.
Rebecca R VanderpoolDivision of Cardiovascular Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.
Roberto BadagliaccaDepartment of Cardiovascular and Respiratory Science, Sapienza University of Rome, Rome, Italy.
Tobore ToboreActelion Pharmaceuticals US, Inc, Titusville, NY.
Mohammad RahmanActelion Pharmaceuticals US, Inc, Titusville, NY.
Carmine Dario VizzaDepartment of Cardiovascular and Respiratory Science, Sapienza University of Rome, Rome, Italy.
Shili LinDepartment of Statistics, The Ohio State University, Columbus, OH.
Allen D EverettDepartment of Pediatric Cardiology, Johns Hopkins University, Baltimore, MD.
Scott H VisovattiDivision of Cardiovascular Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH.
Raymond L BenzaDepartment of Cardiology, Mount Sinai Icahn School of Medicine, New York, NY. Electronic address: chenza.consulting@gmail.com.

Funding

PHORA-Pulmonary Hypertension Outcome Risk AssessmentR01HL164906 · NHLBI · SENTARA HEALTH · PI RAYMOND Louis Benza · 2022 to 2026
$3.0M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pulmonary Arterial HypertensionFamilial Primary Pulmonary HypertensionHumansRisk Assessment

Identifiers

PMID37709252
PMCPMC11075177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.